On October 27, 2021, pursuant to the Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device Action Plan (Action Plan), the US Food and Drug Administration (FDA) released ...
This week the U.S. Food and Drug Administration (FDA), along with Health Canada and the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA), identified 10 guiding principles to ...
Machine Learning has been an ongoing focus of FDA activity for some time. The first Industry Discussion Paper on the topic was launched back in 2019, followed by an Action Plan in 2021 aimed at ...
The FDA is joining hands with fellow regulators in Canada and the U.K. to present 10 principles outlining best practices in the development of artificial intelligence-powered healthcare programs and ...
However, by the late 1970s, there was disappointment that the two main approaches to computing in medicine — rule-based systems and matching, or pattern recognition, systems — had not been as ...
LCGC International’s interview series on the evolving role of artificial intelligence (AI)/machine learning (ML) in separation science continues with Boudewijn Hollebrands from Unilever Foods R&D, ...
Community driven content discussing all aspects of software development from DevOps to design patterns. Over the past few months, I have been helping data engineers, developers, and machine learning ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
The US Food and Drug Administration (FDA), Health Canada, and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) released ten guiding principles for the use of machine learning in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results